Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells

1 Mar 1999

Abstract excerpt

Recombinant adenoviral vectors have promise for human gene therapy because of efficient transgene expression in nondividing primary cell types. Dendritic cells (DC) have potential as adjuvants for immune therapy, since they are specialized to capture antigens to form MHC-peptide complexes, migrate to T cell areas in the lymph node, and activate T cells including CD4+ helpers and CD8+ cytotoxic T lymphocytes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10092101
DOI: 10.1002/(sici)1521-4141(199903)29:03<964::aid-immu964>3.0.co;2-p

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cellsPMID 10092101Read ↗

Dendritic cells transfected with adenoviral vectors as vaccines.Semantic proximity Read ↗

Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing SubsetSemantic proximity Read ↗

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.Semantic proximity Read ↗

Recombinant adenovirus type 5 vectors that target DC-SIGN, ChemR23 and alpha(v)beta3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens.Semantic proximity Read ↗

Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector.Semantic proximity Read ↗

Breaking Entry- and Species Barriers: LentiBOOST® Plus Polybrene Enables High Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5Semantic proximity Read ↗

Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity.Semantic proximity Read ↗

Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses.Semantic proximity Read ↗

Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future PerspectivesSemantic proximity Read ↗

The Challenge for Gene Therapy: Innate Immune Response to AdenovirusesSemantic proximity Read ↗

Breaking Entry-and Species Barriers: LentiBOOST® Plus Polybrene Enhances Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5.Semantic proximity Read ↗

Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.